Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Page 1
Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.
Gammie JS, Chu MWA, Falk V, Overbey JR, Moskowitz AJ, Gillinov M, Mack MJ, Voisine P, Krane M, Yerokun B, Bowdish ME, Conradi L, Bolling SF, Miller MA, Taddei-Peters WC, Jeffries NO, Parides MK, Weisel R, Jessup M, Rose EA, Mullen JC, Raymond S, Moquete EG, O'Sullivan K, Marks ME, Iribarne A, Beyersdorf F, Borger MA, Geirsson A, Bagiella E, Hung J, Gelijns AC, O'Gara PT, Ailawadi G; CTSN Investigators. Gammie JS, et al. N Engl J Med. 2022 Jan 27;386(4):327-339. doi: 10.1056/NEJMoa2115961. Epub 2021 Nov 13. N Engl J Med. 2022. PMID: 34767705 Free PMC article. Clinical Trial.
Whether reduced progression of tricuspid regurgitation results in long-term clinical benefit can be determined only with longer follow-up. ...
Whether reduced progression of tricuspid regurgitation results in long-term clinical benefit can be determined only with longer follo …
Comparison of long-term safety and efficacy outcomes after drug-eluting and bare-metal stent use across racial groups: Insights from NHLBI Dynamic Registry.
Olafiranye O, Vlachos H, Mulukutla SR, Marroquin OC, Selzer F, Kelsey SF, Williams DO, Strollo PJ, Reis SE, Lee JS, Smith AJC. Olafiranye O, et al. Among authors: williams do. Int J Cardiol. 2015 Apr 1;184:79-85. doi: 10.1016/j.ijcard.2015.01.071. Epub 2015 Jan 27. Int J Cardiol. 2015. PMID: 25697874 Free PMC article.
Whether DES has better long-term clinical outcomes compared to BMS across racial groups remains to be established. Accordingly, we assessed whether longer-term clinical outcomes are better with DES compared to BMS across racial groups. ...
Whether DES has better long-term clinical outcomes compared to BMS across racial groups remains to be established. Accordingly, we as …
Surgical treatment of moderate ischemic mitral regurgitation.
Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, Hung JW, Parides MK, Ailawadi G, Perrault LP, Acker MA, Argenziano M, Thourani V, Gammie JS, Miller MA, Pagé P, Overbey JR, Bagiella E, Dagenais F, Blackstone EH, Kron IL, Goldstein DJ, Rose EA, Moquete EG, Jeffries N, Gardner TJ, O'Gara PT, Alexander JH, Michler RE; Cardiothoracic Surgical Trials Network Investigators. Smith PK, et al. N Engl J Med. 2014 Dec 4;371(23):2178-88. doi: 10.1056/NEJMoa1410490. Epub 2014 Nov 18. N Engl J Med. 2014. PMID: 25405390 Free PMC article. Clinical Trial.
Thus, at 1 year, this trial did not show a clinically meaningful advantage of adding mitral-valve repair to CABG. Longer-term follow-up may determine whether the lower prevalence of mitral regurgitation translates into a net clinical benefit. ...
Thus, at 1 year, this trial did not show a clinically meaningful advantage of adding mitral-valve repair to CABG. Longer-term follow- …
Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry.
Mulukutla SR, Marroquin OC, Vlachos HA, Selzer F, Toma C, Kip KE, Abbott JD, Holper E, Lee JS, Khandhar S, Kutcher M, Kelsey S, Smith C, Faxon D, Williams DO. Mulukutla SR, et al. Among authors: williams do. Am J Cardiol. 2013 Feb 15;111(4):486-92. doi: 10.1016/j.amjcard.2012.10.030. Epub 2012 Dec 1. Am J Cardiol. 2013. PMID: 23211356 Free PMC article. Clinical Trial.
Direct stenting compared to balloon predilation in drug-eluting stents: one-year outcomes from the DEScover Registry.
Abbott JD, Earl T, Vlachos HE, Selzer F, Vaidya KA, Romero A, Kip KE, Williams DO. Abbott JD, et al. Among authors: williams do. Catheter Cardiovasc Interv. 2012 Jan 1;79(1):84-9. doi: 10.1002/ccd.22914. Epub 2011 Mar 16. Catheter Cardiovasc Interv. 2012. PMID: 21413133
CONCLUSIONS: DS with DES is commonly performed in clinical practice and results in similar long-term outcomes as predilation....
CONCLUSIONS: DS with DES is commonly performed in clinical practice and results in similar long-term outcomes as predilation....
Comparison of drug-eluting and bare metal stents for saphenous vein graft lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry).
Baldwin DE, Abbott JD, Trost JC, Vlachos HA, Selzer F, Glaser R, Wilensky RL, Slater JN, Doucet S, Naidu SS, Aronow HD, Williams DO. Baldwin DE, et al. Among authors: williams do. Am J Cardiol. 2010 Oct 1;106(7):946-51. doi: 10.1016/j.amjcard.2010.05.025. Epub 2010 Aug 11. Am J Cardiol. 2010. PMID: 20854955 Free PMC article. Clinical Trial.
The effectiveness and safety of drug-eluting stents (DES) compared with bare-metal stents (BMS) in saphenous vein graft (SVG) disease remains unclear. In particular, there is a paucity of data on long-term outcomes. In this study, 395 patients enrolled in the National Hear …
The effectiveness and safety of drug-eluting stents (DES) compared with bare-metal stents (BMS) in saphenous vein graft (SVG) disease remain …
Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries.
Venkitachalam L, Kip KE, Selzer F, Wilensky RL, Slater J, Mulukutla SR, Marroquin OC, Block PC, Williams DO, Kelsey SF; Investigators of NHLBI-Sponsored 1985-1986 PTCA and 1997-2006 Dynamic Registries. Venkitachalam L, et al. Among authors: williams do. Circ Cardiovasc Interv. 2009 Feb;2(1):6-13. doi: 10.1161/CIRCINTERVENTIONS.108.825323. Epub 2008 Dec 15. Circ Cardiovasc Interv. 2009. PMID: 20031687 Free PMC article.
BACKGROUND: Percutaneous coronary intervention (PCI) has undergone rapid progress, both in technology and adjunct therapy. However, documentation of long-term temporal trends in relation to contemporary practice is lacking. ...
BACKGROUND: Percutaneous coronary intervention (PCI) has undergone rapid progress, both in technology and adjunct therapy. However, document …
The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention.
Kip KE, Hollabaugh K, Marroquin OC, Williams DO. Kip KE, et al. Among authors: williams do. J Am Coll Cardiol. 2008 Feb 19;51(7):701-7. doi: 10.1016/j.jacc.2007.10.034. J Am Coll Cardiol. 2008. PMID: 18279733 Free article. Review.
OBJECTIVES: Our purpose was to evaluate the heterogeneity and validity of composite end points, major adverse cardiac events (MACE) in particular, in cardiology research. BACKGROUND: The term MACE is a commonly used end point for cardiovascular research. ...CONCLUSIONS: Va …
OBJECTIVES: Our purpose was to evaluate the heterogeneity and validity of composite end points, major adverse cardiac events (MACE) in parti …
The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
Moses JW, Weisz G, Mishkel G, Caputo R, O'shaughnessey C, Wong SC, Fischell TA, Mooney M, Williams DO, Popma JJ, Fitzgerald P, Smith S, Kuntz RE, Collins M, Cohen SA, Leon MB. Moses JW, et al. Among authors: williams do. Catheter Cardiovasc Interv. 2007 Oct 1;70(4):505-12. doi: 10.1002/ccd.21162. Catheter Cardiovasc Interv. 2007. PMID: 17896408 Clinical Trial.
CONCLUSIONS: In patients similar to those treated in the SIRIUS trial, direct stenting using sirolimus-eluting stents achieves excellent short- and long-term clinical and angiographic results with shorter procedure time and less frequent stent edge restenosis compared with …
CONCLUSIONS: In patients similar to those treated in the SIRIUS trial, direct stenting using sirolimus-eluting stents achieves excellent sho …
30 results